PG
0
Active Trials
0
Total Trials
0
Organizations
0
Events
Papua New Guinea
Medical Only (Private)
Reimbursed Care Access
Papua New Guinea maintains a conventional, restrictive approach to classical psychedelics: most classical psychedelics (psilocybin, MDMA, DMT, mescaline, 5‑MeO‑DMT, 2C‑X, ibogaine and ayahuasca preparations) are effectively controlled and have no authorised medical/reimbursement pathway outside approved research. Ketamine is widely used as an essential anaesthetic across PNG health facilities, whereas esketamine (Spravato) has no documented national regulatory listing or routine reimbursement pathway in PNG.
No clinical trials found for this country yet.